Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor

John A. Dilger, Edwin H. Rho, Florencia Que, Juraj Sprung

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Octreotide may be a life-saving treatment in the case of an acute carcinoid crisis, but when given as an IV bolus in larger doses, it may cause significant effects on the cardiac conduction system. We describe cardiac conduction impairment observed during octreotide administration in a patient undergoing carcinoid tumor surgery. In this patient, IV boluses of 100 μg of octreotide resulted in symptomatic bradycardia, Mobitz type II atrioventricular block, and complete heart block. Perioperative physicians especially need to be aware of these potential effects because they may be more likely to occur during surgery because of the larger doses and boluses that are used to treat acute symptoms secondary to tumor manipulation.

Original languageEnglish (US)
Pages (from-to)318-320
Number of pages3
JournalAnesthesia and analgesia
Volume98
Issue number2
DOIs
StatePublished - Jan 1 2004

Fingerprint

Heart Block
Octreotide
Carcinoid Tumor
Bradycardia
Atrioventricular Block
Physicians
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor. / Dilger, John A.; Rho, Edwin H.; Que, Florencia; Sprung, Juraj.

In: Anesthesia and analgesia, Vol. 98, No. 2, 01.01.2004, p. 318-320.

Research output: Contribution to journalArticle

Dilger, John A. ; Rho, Edwin H. ; Que, Florencia ; Sprung, Juraj. / Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor. In: Anesthesia and analgesia. 2004 ; Vol. 98, No. 2. pp. 318-320.
@article{8384215c14df44669adb71bc71d44494,
title = "Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor",
abstract = "Octreotide may be a life-saving treatment in the case of an acute carcinoid crisis, but when given as an IV bolus in larger doses, it may cause significant effects on the cardiac conduction system. We describe cardiac conduction impairment observed during octreotide administration in a patient undergoing carcinoid tumor surgery. In this patient, IV boluses of 100 μg of octreotide resulted in symptomatic bradycardia, Mobitz type II atrioventricular block, and complete heart block. Perioperative physicians especially need to be aware of these potential effects because they may be more likely to occur during surgery because of the larger doses and boluses that are used to treat acute symptoms secondary to tumor manipulation.",
author = "Dilger, {John A.} and Rho, {Edwin H.} and Florencia Que and Juraj Sprung",
year = "2004",
month = "1",
day = "1",
doi = "10.1213/01.ANE.0000097170.27056.08",
language = "English (US)",
volume = "98",
pages = "318--320",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor

AU - Dilger, John A.

AU - Rho, Edwin H.

AU - Que, Florencia

AU - Sprung, Juraj

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Octreotide may be a life-saving treatment in the case of an acute carcinoid crisis, but when given as an IV bolus in larger doses, it may cause significant effects on the cardiac conduction system. We describe cardiac conduction impairment observed during octreotide administration in a patient undergoing carcinoid tumor surgery. In this patient, IV boluses of 100 μg of octreotide resulted in symptomatic bradycardia, Mobitz type II atrioventricular block, and complete heart block. Perioperative physicians especially need to be aware of these potential effects because they may be more likely to occur during surgery because of the larger doses and boluses that are used to treat acute symptoms secondary to tumor manipulation.

AB - Octreotide may be a life-saving treatment in the case of an acute carcinoid crisis, but when given as an IV bolus in larger doses, it may cause significant effects on the cardiac conduction system. We describe cardiac conduction impairment observed during octreotide administration in a patient undergoing carcinoid tumor surgery. In this patient, IV boluses of 100 μg of octreotide resulted in symptomatic bradycardia, Mobitz type II atrioventricular block, and complete heart block. Perioperative physicians especially need to be aware of these potential effects because they may be more likely to occur during surgery because of the larger doses and boluses that are used to treat acute symptoms secondary to tumor manipulation.

UR - http://www.scopus.com/inward/record.url?scp=1642541879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642541879&partnerID=8YFLogxK

U2 - 10.1213/01.ANE.0000097170.27056.08

DO - 10.1213/01.ANE.0000097170.27056.08

M3 - Article

C2 - 14742361

AN - SCOPUS:1642541879

VL - 98

SP - 318

EP - 320

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -